Figure 3From: Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome Kaplan–Meier analysis of metastasis-free survival. Kaplan–Meier analysis (metastasis-free survival) using (a) E2F1 expression (30th percentile) and the 70-gene signature, (B) intrinsic subtypes, (c) the recurrence score (Rsu), and (b) the wound response signature. CI, 95% confidence interval; HR, hazard ratio.Back to article page